Navigating the New Adult RSV Vaccination Recommendations

In this episode, “Navigating the New Adult RSV Vaccination Recommendations,” the expert pharmacists explore the following questions:

1. The respiratory syncytial virus (RSV) recommendations for adults changed recently. What vaccines are available for adults, who should be vaccinated, and when?
2. How do you differentiate these vaccine options for all patients at risk of RSV?

The expert pharmacists examined recent shifts in adult RSV vaccination recommendations, clarifying that all adults 75 years or older should receive the vaccine, and that those aged 50 to 74 years with certain high-risk conditions are also eligible. They reviewed the 3 available vaccine options, noting their different approved age indications and that only one is indicated for use during pregnancy. The experts emphasized that RSV vaccination is currently a 1-time dose, preferably administered in late summer or early fall before the respiratory season peaks, and is not repeated annually. This discussion provides pharmacists with a clear framework for identifying eligible patients and differentiating vaccine options in practice.

Throughout the conversation, the experts offer a comprehensive reflection on the field and the factors that may shape clinicians’ approach to care moving forward.